News

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.
The new procedure uses heat energy to target cancer cells without damaging healthy tissue. It is only offered through the ...
Outpatient administration of CAR T-cell therapies can reduce costs and improve patient satisfaction, with evolving ...
Health policy is crucial for advancing clinical research and ensuring accessibility and funding for novel therapies.
As of December 31, 2024, Can-Fite had cash and cash equivalents and short term deposits of $7.88 million as compared to $8.90 million as of December 31, 2023. The decrease in cash during the year ...
Cancer Stem Cell Market Cancer stem cells (CSCs) are a distinct subset of tumor cells with stem-like properties, including self-renewal and ...
A spit test, developed by London's Institute of Cancer Research, can help detect prostrate cancer better than the ...
A new study found a correlation between regular use of a popular over the counter drug and a decreased risk in certain types ...
Researchers have developed innovative compounds capable of precisely targeting cancer cells when activated by light. This ...
Paul Cauthen announced he has cancer just weeks ago, but he apparently is not slowing down much. He already announced shows ...
Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...
FMT is a novel therapeutic approach that involves transferring microbiota from a healthy donor to a patient's ...